These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11328772)

  • 41. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.
    Firsov AA; Alferova IV; Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2005 May; 25(5):409-13. PubMed ID: 15848296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
    Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
    J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
    Croisier D; Chavanet P; Lequeu C; Ahanou A; Nierlich A; Neuwirth C; Piroth L; Duong M; Buisson M; Portier H
    J Antimicrob Chemother; 2002 Sep; 50(3):349-60. PubMed ID: 12205059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients.
    Traunmüller F; Thalhammer-Scherrer R; Locker GJ; Losert H; Schmid R; Staudinger T; Thalhammer F
    J Antimicrob Chemother; 2001 Feb; 47(2):229-31. PubMed ID: 11157914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
    Perrig M; Acosta F; Cottagnoud M; Gerber CM; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2001 May; 47(5):701-4. PubMed ID: 11328789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar.
    Ishida Y; Kurosaka Y; Murakami Y; Otani T; Yamaguchi K
    Chemotherapy; 1999; 45(3):183-91. PubMed ID: 10224340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An experimental meningitis with Streptococcus pneumoniae in rats: therapeutic effect of aspoxicillin and its penetration into CSF.
    Yamaguchi T; Kasuga O; Okuno S; Maezawa I
    Drugs Exp Clin Res; 1989; 15(6-7):297-301. PubMed ID: 2591300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
    Pea F; Di Qual E; Cusenza A; Brollo L; Baldassarre M; Furlanut M
    Clin Pharmacokinet; 2003; 42(6):589-98. PubMed ID: 12793843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Lehr KH; Ren J
    J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.
    Deryke CA; Du X; Nicolau DP
    J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography.
    Cheng FC; Tsai TR; Chen YF; Hung LC; Tsai TH
    J Chromatogr A; 2002 Jun; 961(1):131-6. PubMed ID: 12186384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rifabutin for experimental pneumococcal meningitis.
    Schmidt H; Zysk G; Reinert RR; Brück W; Stringaris A; Chen V; Stuertz K; Fischer F; Bartels R; Schaper KJ; Weinig S; Nau R
    Chemotherapy; 1997; 43(4):264-71. PubMed ID: 9209783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.
    Nahata MC; Kohlbrenner VM; Barson WJ
    Chemotherapy; 1993; 39(1):1-5. PubMed ID: 8444056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses.
    Chow AT; Chen A; Lattime H; Morgan N; Wong F; Fowler C; Williams RR
    J Clin Pharm Ther; 2002 Apr; 27(2):143-50. PubMed ID: 11975700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levofloxacin pharmacokinetics in children.
    Chien S; Wells TG; Blumer JL; Kearns GL; Bradley JS; Bocchini JA; Natarajan J; Maldonado S; Noel GJ
    J Clin Pharmacol; 2005 Feb; 45(2):153-60. PubMed ID: 15647407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin.
    Drugeon HB; Juvin ME; Bryskier A
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():55-9. PubMed ID: 10404339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis.
    Tarasi A; Dever LL; Tomasz A
    J Antimicrob Chemother; 1997 May; 39 Suppl A():121-7. PubMed ID: 9511076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.